Similarly, in hematologic malignancies like diffuse large B-cell lymphoma and acute myeloid leukemia, high CD47 expression has been correlated with worse clinical outcomes and resistance to treatment [21,22]. The gene discussed is CD47; the disease is acute myeloid leukemia.